Literature DB >> 14976318

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.

Scott W Altmann1, Harry R Davis, Li-Ji Zhu, Xiaorui Yao, Lizbeth M Hoos, Glen Tetzloff, Sai Prasad N Iyer, Maureen Maguire, Andrei Golovko, Ming Zeng, Luquan Wang, Nicholas Murgolo, Michael P Graziano.   

Abstract

Dietary cholesterol consumption and intestinal cholesterol absorption contribute to plasma cholesterol levels, a risk factor for coronary heart disease. The molecular mechanism of sterol uptake from the lumen of the small intestine is poorly defined. We show that Niemann-Pick C1 Like 1(NPC1L1) protein plays a critical role in the absorption of intestinal cholesterol. NPC1L1 expression is enriched in the small intestine and is in the brush border membrane of enterocytes. Although otherwise phenotypically normal, NPC1L1-deficient mice exhibit a substantial reduction in absorbed cholesterol, which is unaffected by dietary supplementation of bile acids. Ezetimibe, a drug that inhibits cholesterol absorption, had no effect in NPC1L1 knockout mice, suggesting that NPC1L1 resides in an ezetimibe-sensitive pathway responsible for intestinal cholesterol absorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976318     DOI: 10.1126/science.1093131

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  448 in total

1.  Biomedicine. Will the real cholesterol transporter please stand up.

Authors:  Eric L Klett; Shailesh B Patel
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

2.  Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis.

Authors:  Jaideep Behari; Naga Chalasani
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

3.  Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis.

Authors:  Masato Yoneda; Koji Fujita; Kento Imajo; Hironori Mawatari; Hiroyuki Kirikoshi; Satoru Saito; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2010-12-22       Impact factor: 7.527

4.  DISP3, a sterol-sensing domain-containing protein that links thyroid hormone action and cholesterol metabolism.

Authors:  Martina Zikova; Alicia Corlett; Zdenka Bendova; Petr Pajer; Petr Bartunek
Journal:  Mol Endocrinol       Date:  2009-01-29

5.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 6.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 7.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

8.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 9.  Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.

Authors:  Shailendra B Patel
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 10.  New compounds able to control hepatic cholesterol metabolism: Is it possible to avoid statin treatment in aged people?

Authors:  Laura Trapani; Marco Segatto; Valentina Pallottini
Journal:  World J Hepatol       Date:  2013-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.